Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation

Mov Disord. 2008 Apr 30;23(6):904-7. doi: 10.1002/mds.22002.

Abstract

We report the results of iron chelating treatment with deferiprone in a 61-year-old woman with signs and symptoms of neurodegeneration with brain iron accumulation (NBIA). After 6 months of therapy the patient's gait had improved and a reduction in the incidence of choreic dyskinesias was observed. Her gait returned to normal after an additional 2 months of therapy, at which time there was a further reduction in involuntary movements and a partial resolution of the blepharospasm.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Brain / metabolism*
  • Brain / pathology
  • Dyskinesias / drug therapy
  • Dyskinesias / pathology*
  • Female
  • Humans
  • Iron / metabolism*
  • Iron Chelating Agents / therapeutic use*
  • Magnetic Resonance Imaging
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / pathology*
  • Treatment Outcome

Substances

  • Iron Chelating Agents
  • Iron